Pathology · Hematological Malignancies (Leukemias, Lymphomas, Myeloma)

A pediatric patient has mediastinal mass, lymphadenopathy, and peripheral blood shows lymphoblasts. Flow cytometry: TdT+, CD19+, CD10+, CD34+. Cytogenetics reveals a hyperdiploid karyotype (>50 chromosomes). What is the prognostic significance of this karyotype in B-ALL?

  • A Favorable prognosis with excellent response to standard chemotherapy
  • B Poor prognosis requiring allogeneic stem cell transplant in first remission
  • C Neutral prognosis; requires Philadelphia chromosome testing before risk stratification
  • D Poor prognosis due to drug resistance conferred by extra chromosomes
Correct answer: A. Favorable prognosis with excellent response to standard chemotherapy

Explanation

Hyperdiploidy (>50 chromosomes, particularly gains of chromosomes 4, 10, 17, 21) in B-ALL is a favorable cytogenetic finding, associated with excellent event-free survival exceeding 85–90% with standard chemotherapy. The mechanism involves enhanced sensitivity to antimetabolites (methotrexate, mercaptopurine) due to increased uptake via additional copies of transporter genes. Hypodiploidy (<44 chromosomes) or t(9;22) (Philadelphia chromosome) confer poor prognosis requiring intensified treatment or SCT.

Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 23,000+ MCQs.

Start free → Log in

More Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs

See all Hematological Malignancies (Leukemias, Lymphomas, Myeloma) MCQs →